Shots:

• The collaboration will deploy Biofourmis' Biovitals platform to co-develop a novel digital technology for the objective assessment of pain using biosensors and AI-based algorithms. The solutions will be validated in the global study that enrolls 120+ endometriosis patients
• The digital solution for managing patients with endometriosis in an ambulatory setting will include a wearable- clinical-grade biosensor to capture physiology biomarkers and a mobile app to monitor symptoms- with a gamification engine for patient engagement
• The technology applies analytics to physiology biomarkers for quantification of pain and will include a clinician-facing web dashboard for remote review and intervention.  Chugai is demonstrating its commitment to applying the advanced digital technologies for better understanding the real-life needs of patients and to develop innovative solutions for society- as outlined in the CHUGAI DIGITAL VISION 2030

  Ref: PRNewswire | Image: Biofourmis